Harbour Investments, Inc. Lantern Pharma Inc. Call Options Transaction History
Harbour Investments, Inc.
- $3.26 Billion
- Q4 2024
Call Options
0 transactions
| Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
|---|
Others Institutions Holding LTRN
# of Institutions
34Shares Held
2.48MCall Options Held
39.8KPut Options Held
6.1K-
Bios Capital Management, LP Fort Worth, TX1.21MShares$5.94 Million4.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA364KShares$1.79 Million0.0% of portfolio
-
Cm Management, LLC200KShares$984,0000.6% of portfolio
-
New Edge Advisors, LLC New Orleans, LA137KShares$675,7020.0% of portfolio
-
Geode Capital Management, LLC Boston, MA87.4KShares$430,1800.0% of portfolio
About Lantern Pharma Inc.
- Ticker LTRN
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 10,830,900
- Market Cap $53.3M
- Description
- Lantern Pharma Inc., a clinical stage biotechnology company, focuses on artificial intelligence, machine learning, and genomic data to streamline the drug development process. Its advanced drug candidate is LP-100, which is in phase II clinical trials to treat metastatic, castration-resistant, and prostate cancer. The company also develops LP-30...